Search Results
Oct 13, 2025, 10:17 ET Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
13.4%, respectively.1 There were no trial discontinuations attributed to CT-155 and two (2) for the digital control arm. There were no serious AEs related to either group.1 Approximately 3.7 million adults in the U.S. live with schizophrenia, which places a profound
More news about: Boehringer Ingelheim Pharmaceuticals, Inc.; Click Therapeutics
Oct 10, 2025, 17:00 ET AES Announces Quarterly Dividend
"Investors" then "Stock Information" and then "Dividend History." About AES The AES Corporation (NYSE: AES) is a Fortune 500 global energy company accelerating the future of energy. Together with our many stakeholders,
More news about: The AES Corporation
Oct 09, 2025, 06:30 ET INTEGRA ANNOUNCES RESULTS FROM NEAR-MINE OXIDE GOLD DRILLING AT FLORIDA CANYON; INITIAL DUMP VOLUME AND GRADE ESTIMATES UNDERSCORE NEAR-TERM GROWTH POTENTIAL
pulverizing a 300 g split to >85% passing 75 microns. Gold analysis was performed on a 30-gram pulp using fire assay with ICP-AES finish. Samples returning >10 ppm Au were re-assayed using a gravimetric finish. Additionally, samples with Au >0.156 ppm underwent cyanide-soluble
More news about: Integra Resources Corp.
Oct 08, 2025, 17:55 ET High Recovery Caesium Concentrate Produced from Latest Metallurgical Testwork at Shaakichiuwaanaan
concentrates were assayed by SGS Canada Inc for Cs and whole rock by borate fusion XRF, as well as multi-element by sodium peroxide fusion with ICP-AES / ICP-MS. Pollucite
More news about: PMET Resources Inc.
Oct 06, 2025, 17:00 ET AES Announces Third Quarter 2025 Financial Review Conference Call to be Held on Wednesday, November 5, 2025 at 10:00 a.m. ET
About AES The AES Corporation (NYSE: AES) is a Fortune 500 global energy
More news about: The AES Corporation
Oct 06, 2025, 07:30 ET BTQ Technologies Welcomes Radical Semiconductor Founders as Full-Time Hires to Accelerate Post-Quantum Commercialization
centric acceleration architecture for post-quantum cryptography that delivers up to one million digital signatures per second, up to five times faster AES performance, ultra low power, and a compact footprint. It supports current and next generation standards and targets payments, Internet of Things, identity,
More news about: BTQ Technologies Corp.
Oct 03, 2025, 09:00 ET WiMi Researches Technology to Generate Encryption Keys Using Quantum Generative Adversarial Networks, Creating a Highly Secure Encryption Key Generator
encrypt user data, preventing data from being stolen or tampered with during transmission and storage. Traditional encryption algorithms, such as RSA and AES, have ensured data security to a certain extent, but with the continuous improvement of computing power, their security faces challenges. Quantum encryption
More news about: WiMi Hologram Cloud Inc.
Sep 29, 2025, 08:00 ET U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
90. Safety data through Week 16 showed that 42% of patients receiving guselkumab and 68% of patients receiving placebo reported adverse events (AEs). Common AEs experienced by patients receiving guselkumab included nasopharyngitis, upper respiratory tract infection and COVID-19. No serious or opportunistic
More news about: Johnson & Johnson
Sep 29, 2025, 06:00 ET AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress
ROC-101, the most common treatment emergent adverse events (TEAEs) were headache (n=2) and constipation (n=3).There were no serious AEs, discontinuations due to AEs, or clinically significant treatment-emergent alterations in the electrical activity of the heart as recorded by an electrocardiogram.
More news about: AllRock Bio
Sep 29, 2025, 06:00 ET Ragie Unveils Agent Ready Capabilities at Launch Week
Compliance Trust remains core to Ragie's mission. Ragie is SOC 2 Type II, GDPR, and HIPAA compliant, with AES-256 encryption for data at rest and TLS for data in transit. Role-based access, partition-level isolation, and strict data boundaries ensure enterprise-grade
More news about: Ragie
Sep 25, 2025, 14:01 ET U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
administration, this therapy provides a meaningful alternative treatment option for this patient population." In EMBER-3, the majority of adverse events (AEs) with Inluriyo were low grade (Grade 1-2) and the most common adverse reactions (≥10%), including laboratory abnormalities, were hemoglobin decreased,
More news about: Eli Lilly and Company
Sep 25, 2025, 07:30 ET Pantherun Technologies to Showcase 'Pepper' at Altera Innovator's Day 2025
latency-free AES encryption, Pepper ensures strong security at the fastest network speeds, ideal for powering IoTs, sensors, cameras, switches, routers, and industrial systems. Key highlights of Pepper: Advanced security: Built-in AES encryption,
More news about: Pantherun Technologies
Sep 23, 2025, 14:37 ET HIKSEMI představuje inteligentní úložiště pro digitální věk na Obchodní výstavě Čína-Střední Asie 2025
summitu Global Flash prestižní „Zlatou cenou za produkt SSD roku 2025", byl vyzdvižen pro svou spolehlivost na úrovni datových center, podporu šifrování AES-256 a výjimečný výkon v prostředí s vysokou účinností a vysokými nároky. Tento scénářový přístup k výstavě podtrhl závazek společnosti HIKSEMI
More news about: Hiksemi
Sep 23, 2025, 10:00 ET Augmentir Expands its AI Platform with New Augmented Reality (AR) Features for Connected Workers in Manufacturing
by AI to deliver measurable value where it matters most. Showcasing AR Innovation at AES Augmentir is showcasing these new AR features this week at the Augmented Enterprise Summit (AES) in Dallas, TX. Attendees will see firsthand how Augmentir's AR
More news about: Augmentir, Inc.
Sep 22, 2025, 15:55 ET HIKSEMI представляет интеллектуальные системы хранения данных для эпохи цифровых технологий на выставке «Китай -- Центральная Азия 2025»
SSD-продукт 2025 года» на Global Flash Summit, был отмечен за свою надежность, отвечающую уровню центров обработки данных, поддержку алгоритма шифрования AES-256 и исключительную производительность в высокоэффективных средах с высокой частотой запросов. Такой подход к организации экспозиции,
More news about: Hiksemi
Sep 22, 2025, 11:01 ET Electronic Signature Software Market Is Projected To Reach US$35.71 Billion By 2031 At CAGR Of 34.6% | Insight Partners
added support for the following providers and eID procedures in generating qualified electronic signatures (QES) and advanced electronic signatures (AES) via eID-based signer authentication - certME (Romania), Adacom One-Shot, Intesi (Finland)
More news about: The Insight Partners
Sep 22, 2025, 08:00 ET For more secure AI and ML models: Infineon's OPTIGA™ Trust M backs Thistle Technologies' Secure Edge AI solution
encryption key is secured by OPTIGA Trust M security solution. Each device has a unique AES 256-bit key securely stored in OPTIGA Trust M, which is used to secure the AI Model encryption key. This means that the AES key is used for encryption and decryption inside the OPTIGA Trust M only. Even if a device
More news about: Thistle Technologies
Sep 22, 2025, 04:45 ET Targi China-Central Asia Expo 2025 - HIKSEMI prezentuje zaawansowane rozwiązania w zakresie przechowywania danych w erze cyfrowej
Nagrody dla produktu SSD roku 2025" podczas Światowego Szczytu Flash, został wyróżniony za niezawodność na poziomie centrów danych, obsługę szyfrowania AES-256 oraz nadzwyczajną wydajność w środowiskach o zwiększonej wydajności i wysokich wymaganiach. Taka koncepcja wystawy oparta na
More news about: Hiksemi
Sep 22, 2025, 04:36 ET HIKSEMI predstavuje inteligentné úložisko pre digitálnu éru na výstave China-Central Asia Expo 2025
za SSD produkt roka 2025" na konferencii Global Flash Summit, bol vyzdvihnutý pre svoju spoľahlivosť na úrovni dátových centier, podporu šifrovania AES-256 a výnimočný výkon vo vysoko efektívnom prostredí s vysokými nárokmi. Tento prístup na výstave zameraný na scenáre zdôraznil odhodlanie
More news about: Hiksemi
Sep 18, 2025, 21:27 ET HIKSEMI Showcases Smart Storage for the Digital Age at 2025 China-Central Asia Expo
prestigious "Gold Award for SSD Product of the Year 2025" at the Global Flash Summit, was highlighted for its data-center-grade reliability, support for AES-256 encryption, and exceptional performance in high-efficiency, high-demand environments. This scenario-driven exhibition approach underscored
More news about: Hiksemi
Sep 18, 2025, 09:00 ET QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025
gastrointestinal adverse events (AEs) was similar to that of marketed GLP-1 RA products. The most common treatment-related AEs were nausea, vomiting, and diarrhea, all which occurred mainly during the GLP-1 RA common dose escalation period. Thereafter, these AEs decreased after the target
More news about: QL Biopharm
Sep 18, 2025, 08:42 ET Nearly 20% of US IT Security Practitioners Cite Attacks on Backups as Primary Cause of Data Breach, According to Research From Apricorn
Apricorn, the leading manufacturer of software-free, 256-bit AES XTS hardware-encrypted USB drives, today announced the results of its latest annual survey of US IT security decision makers, revealing serious gaps
More news about: Apricorn
Sep 17, 2025, 20:15 ET CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), delayed neurotoxicities, second primary malignancy or other delayed AEs on the study. Regarding efficacy: The overall response rate was 100% (95% CI: 76.8, 100.0) with 11 (78.6%) patients achieving complete response
More news about: CARsgen Therapeutics
Sep 17, 2025, 19:30 ET Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
were mild (Grade 1) or moderate (Grade 2). There were no denifanstat (ASC40) -related Grade 3 or 4 TEAEs and no denifanstat (ASC40) -related serious AEs (SAEs). No deaths were reported. No denifanstat (ASC40) -related permanent treatment discontinuations or withdrawals were observed. Detailed data
More news about: Ascletis Pharma Inc.
Sep 17, 2025, 08:00 ET GridStrong Secures $10M in Seed Funding to Automate Grid Compliance and Reliability
industry standards, GridStrong automates compliance workflows to reduce audit risk and deliver results faster. Asset owners like Southern Company, Orsted, AES, Engie, NextEra Energy, Invenergy, Intersect Power, Akuo, Recurrent Energy, and many more rely on GridStrong to meet the demanding requirements of today's
More news about: GridStrong